Mexico Geographic Atrophy Market (2025-2031) | Analysis, Forecast, Share, Competitive Landscape, Industry, Growth, Companies, Trends, Outlook, Segmentation, Value, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Geographic Atrophy Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Geographic Atrophy Market - Industry Life Cycle

3.4 Mexico Geographic Atrophy Market - Porter's Five Forces

3.5 Mexico Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.6 Mexico Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 Mexico Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Mexico

4.2.2 Growing awareness about geographic atrophy and its impact on vision loss

4.2.3 Advancements in diagnostic technologies for early detection and monitoring of geographic atrophy

4.3 Market Restraints

4.3.1 Limited access to specialized eye care services in certain regions of Mexico

4.3.2 High treatment costs associated with managing geographic atrophy

4.3.3 Regulatory challenges in introducing new therapies for geographic atrophy in the Mexican market

6.1 Mexico Geographic Atrophy Market, By Age Group

6.1.1 Overview and Analysis

6.1.2 Mexico Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F

6.1.3 Mexico Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F

6.1.4 Mexico Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F

6.2 Mexico Geographic Atrophy Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 Mexico Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F

6.2.3 Mexico Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F

6.2.4 Mexico Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F

6.3 Mexico Geographic Atrophy Market, By Therapeutic Agents Clinical Phase

6.3.1 Overview and Analysis

6.3.2 Mexico Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F

6.3.3 Mexico Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F

6.3.4 Mexico Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F

7.1 Mexico Geographic Atrophy Market Export to Major Countries

7.2 Mexico Geographic Atrophy Market Imports from Major Countries

8.1 Number of patients diagnosed with geographic atrophy annually

8.2 Adoption rate of advanced diagnostic technologies for geographic atrophy

8.3 Percentage of healthcare professionals trained in the diagnosis and treatment of geographic atrophy

8.4 Patient satisfaction and quality of life improvements post-treatment

8.5 Number of clinical trials and research studies focused on geographic atrophy in Mexico

9.1 Mexico Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.2 Mexico Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 Mexico Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F

10.1 Mexico Geographic Atrophy Market Revenue Share, By Companies, 2024

10.2 Mexico Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters